Jung C, Kalbus M, Fleckenstein B, Melms A, Jung G, Wiesmüller K H
Neurologische Klinik der Universitätsklinik Tübingen, Germany.
J Immunol Methods. 1998 Oct 1;219(1-2):139-49. doi: 10.1016/s0022-1759(98)00139-2.
An efficient screening procedure for the identification of high affinity HLA class II ligands and their binding pattern has been established to characterize peptide specificities for the HLA allele DRB10301. The method is based on the screening of 209 synthetic undecapeptide amide sublibraries O/X10-NH2 representing collections of 19(10) individual peptides in a competition ELISA using HLA DRB10301 protein and the biotinylated natural ligand ApoB 2877-2894. Screening results represent the effect on competition induced by an individual amino acid residue in its sequence position of undecapeptide amides. Amino acids clustered as active in their position were randomly selected for the same position of a restricted set of 96 individual undecapeptide amides. This novel approach for the design of ligands was introduced to compensate for the inaccuracy induced by the translational invariance of amino acids in peptide libraries characterized by one defined amino acid. Translational invariance is facilitated by shifted docking of O/X10-NH2 libraries in the binding cleft and protrusion from the ends of the cleft. A second more directed deduced set of 24 peptides was obtained by combination of the most favourable residues in each position. All individual peptides were investigated in the competition assay. The most active HLA DRB1*0301 ligands were obtained by random selection of favourable amino acids and six of them showed improved affinity in comparison to the model ligand alpha AChR 310-325.
已建立一种高效的筛选程序,用于鉴定高亲和力的HLA II类配体及其结合模式,以表征HLA等位基因DRB10301的肽特异性。该方法基于在竞争ELISA中使用HLA DRB10301蛋白和生物素化的天然配体ApoB 2877-2894,对209个合成十一肽酰胺亚库O/X10-NH2进行筛选,这些亚库代表19(10)个单个肽的集合。筛选结果代表了十一肽酰胺序列位置上单个氨基酸残基对竞争的影响。在其位置上聚类为有活性的氨基酸被随机选择用于一组受限的96个单个十一肽酰胺的相同位置。引入这种设计配体的新方法是为了补偿由以一个定义的氨基酸为特征的肽库中氨基酸的翻译不变性所导致的不准确性。O/X10-NH2库在结合裂隙中的移位对接以及从裂隙末端突出促进了翻译不变性。通过组合每个位置上最有利的残基,获得了第二组更具针对性的24个肽的推导集合。所有单个肽都在竞争试验中进行了研究。通过随机选择有利的氨基酸获得了最具活性的HLA DRB1*0301配体,其中六个与模型配体α AChR 310-325相比显示出更高的亲和力。